Sandoz Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SANDOZ INC, and what generic and branded alternatives to SANDOZ INC drugs are available?
SANDOZ INC has twenty-six approved drugs.
There are nineteen tentative approvals on SANDOZ INC drugs.
Summary for Sandoz Inc
US Patents: | 0 |
Tradenames: | 19 |
Ingredients: | 18 |
NDAs: | 26 |
Patent Litigation for Sandoz Inc: | See patent lawsuits for Sandoz Inc |
PTAB Cases with Sandoz Inc as petitioner: | See PTAB cases with Sandoz Inc as petitioner |
Drugs and US Patents for Sandoz Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sandoz Inc | CISATRACURIUM BESYLATE PRESERVATIVE FREE | cisatracurium besylate | INJECTABLE;INJECTION | 200154-001 | Feb 3, 2012 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Sandoz Inc | CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER | clindamycin phosphate | INJECTABLE;INJECTION | 201692-001 | May 31, 2012 | AP | RX | No | Yes | ⤷ Subscribe | ⤷ Subscribe | ||||
Sandoz Inc | ENOXAPARIN SODIUM | enoxaparin sodium | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | 078660-001 | Nov 28, 2011 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Sandoz Inc | CEFTRIAXONE | ceftriaxone sodium | INJECTABLE;INJECTION | 065204-002 | May 3, 2005 | AP | RX | No | Yes | ⤷ Subscribe | ⤷ Subscribe | ||||
Sandoz Inc | ENALAPRIL MALEATE | enalapril maleate | TABLET;ORAL | 075459-001 | Aug 22, 2000 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.